Search

everythinglearnresearchcommunity

for

Search:↓

Conditioned media from mesenchymal stem cell cultures could be a more effective alternative for regenerative therapies, but more research is needed.

Minoxidil and finasteride treat hair loss; more research needed for other options.

The document concludes that while there are promising methods to control CRISPR/Cas9 gene editing, more research is needed to overcome challenges related to safety and effectiveness for clinical use.

Minoxidil improves blood flow and vessel flexibility, potentially helping with vascular stiffness.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Patient-derived melanocytes can potentially treat vitiligo by restoring skin pigmentation.

Hair can regrow in large wounds through a process similar to how hair forms in embryos, and understanding this could lead to new treatments for hair loss or scarring.

Gene therapy, especially using atoh1, shows promise for creating functional sensory hair cells in the inner ear, but dosing and side effects need to be managed for clinical application.

Different markers are found in stem cells of the scalp's hair follicle bulge and the surrounding skin.

The new lab-grown skin model is good for testing sunscreen's protection against DNA damage from UV light.

Testosterone therapy and surgeries like mastectomy improve transgender men's lives and mental health with low risks and high satisfaction.

New methods like nanoparticles and microneedles show promise for better skin drug delivery, especially for hair disorders.

ARL15 is important for fat cell development and the release of the hormone adiponectin.

The review highlights the need for more research on transgender dermatology, the role of dermatologists in gender affirmation, and the effects of hormone therapy on skin and hair.

Genetic counselors should be culturally skilled and aware of transgender patients' unique health risks and needs.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

The QR 678 hair growth treatment was safe and effective for hair regrowth in men and women.

Healthcare providers need better understanding and cultural sensitivity to improve care for transgender patients with kidney failure needing transplants.

Telocytes have potential in therapy and tissue regeneration, but challenges in identification and cultivation remain.

Transfollicular drug delivery is promising but needs more research to improve and understand it better.

Nanotechnology is improving drug delivery and targeting, with promising applications in cancer treatment, gene therapy, and cosmetics, but challenges remain in ensuring precise delivery and safety.

Minoxidil, finasteride, and low-level laser light therapy are effective FDA-approved treatments for hair loss.

The document concludes that gender-affirming treatments are essential for transgender individuals and outlines safe hormone therapy practices.

Epidermal stem cells show promise for future dermatology treatments due to ongoing advancements.

Environmental factors and exposure to toxins may contribute to male infertility by affecting sperm and hormone function.

The document concludes that identifying the specific cells where skin cancers begin is important for creating better prevention, detection, and treatment methods.

Tideglusib with a bacterial cellulose hydrogel improves wound healing in rats.

Human amniotic stem cells can safely treat psoriasis-like skin in mice.

Lack of certain cells causes abnormal nipple development and nursing failure.

Small extracellular vesicles from stem and immune cells show promise for treating various diseases but face challenges in clinical use.